Description
Description
Indenza – 40mg
Composition: Enzalutamide 40mg
Therapeutic Class: Androgen Receptor Antagonist
Indenza: Trusted by Doctors
Indenza by Aprazer is available worldwide and offers a potential treatment for resistant prostate cancers.
Aprazer Healthcare – High Quality Oncology Medicines
- • Aprazer manufactures a complete range of affordable oncology care therapeutics and ranks as the largest global manufacturer and exporter.
- • WHO- GMP certified, assured therapeutic efficacy and safety.
What is Indenza?
Indenza is a second-generation androgen receptor antagonist that is widely used against advanced and metastatic prostate cancer, which no longer responds to androgen deprivation therapy.
Uses of Indenza
- • Castration Resistant Prostate Cancer
- • Metastatic Castration Resistant Prostate Cancer
- • Hormone-sensitive Castration Resistant Prostate Cancer
How does Indenza work?
- • Prostate cancer cell growth is stimulated by testosterone.
- • Enzalutamide blocks the androgen receptor on cancer cells.
- • Inhibits the binding of testosterone to cancer cells.
- • Shrinks cancer and slows down its growth.
Common Side Effects
- • Dizziness
- • Fatigue
- • Muscle pain
- • Joint pain
- • Diarrhea
- • Skin rashes
- • Dryness
- • Hot flushes
Serious Side Effects
Generally, dose-dependent side effects are seen:
- • QT prolongation, hypertension
- • Elevated liver enzymes
- • Restless leg syndrome, seizures
- • Bone fractures, weakness, pain
- • Irregular heartbeats
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to Enzalutamide or any excipients.
- • Not prescribed for women
- • Breastfeeding mothers
- • Pregnant women
Precautions
Cautiously to be used in patients with:
- • Heart problems
- • High cholesterol levels
- • Diabetic people
- • High blood pressure
- • Brain injury or brain tumor
Warning
To be used under medical prescription only.
Important Safety and Monitoring Information
Regular monitoring of the liver function, cardiac rhythms, and adrenal functions.
